Industry Pipeline - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Pipeline
Interphex Showcase 2010.

Pharmaceutical Technology
Volume 34, Issue 4, pp. 128-135

OUTSOURCING & CONSULTING SERVICES



Contract manufacturing
Cangene bioPharma (formerly Chesapeake Biological Laboratories) offers contract manufacturing for the aseptic fill–finish of liquid and lyophilized sterile injectables into vials and syringes. Cangene provides clinical- and commercial-scale manufacturing, and its clients distribute their products worldwide. Cangene's sites have received approvals from US, European, and Japanese regulatory authorities. Cangene bioPharma, Baltimore, MD http://www.cblinc.com/ tel. 800.441.4225



Protein identification
Orbitrap testing is a protein-identification platform with high sensitivity, rapid scan rate, high mass accuracy and resolution power as high as 100,000. The platform combines a linear, ion-trap mass spectrometer and Orbitrap mass analyzer. Lancaster Laboratories performs comprehensive, accurate identification of proteins in complex sample mixtures. Lancaster Laboratories, Lancaster, PA http://www.lancasterlabs.com/ tel. 717.656.2300



Regulatory services
Dow's strategic guidance early in a topical dermatological program helps speed timing and reduce costs. Dow designs specific nonclinical and chemistry, manufacturing, and controls programs to support applications, negotiates with the US Food and Drug Administration, and prepares submissions. The company recently brought five topical products from inception to approval. Dow Pharmaceutical Sciences, Petaluma, CA http://www.dowpharmsci.com/ tel. 877.369.7476


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here